GGrantIndex
← Search

CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL

$82,604N01FY2025DANIH

Albany Molecular Research, Inc., Albany NY

Investigators

Abstract

The overall objective of this project is for the contractor to support the chemistry, manufacturing, and controls (CMC) development of NCGC00413972 for preclinical safety evaluation and clinical trial. Rare Diseases

View original record on NIH RePORTER →
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL · GrantIndex